Cargando...
Prolonged paradoxical reaction to anti-tuberculous treatment after discontinuation of TNF-alpha- blocker therapy with adalimumab. Rare clinical documentation
In the past decades, tumor necrosis factor alpha (TNF-a) antagonist has been a milestone in the treatment of many chronic inflammatory diseases. TNF antagonist can increase patients’ susceptibility to many different kinds of infections especially those requiring granuloma formations despite regular...
Gardado en:
| Publicado en: | Open Med (Wars) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
De Gruyter Open
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5152954/ https://ncbi.nlm.nih.gov/pubmed/28352675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/med-2015-0009 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|